BONVENTURE
Venture capitalBerlin · Seed–Series B · 19 people tracked
Investment thesis
BONVENTURE focuses on supporting entrepreneurs who combine innovation with social responsibility, particularly in healthcare. The firm invests in business models that address pressing societal challenges while building sustainable, scalable enterprises. They provide not only capital but also operational expertise and experience building impact-driven ventures, with a demonstrated commitment to addressing systemic issues in sectors like primary care and rural healthcare access.
Source: firm website, verified Jul 21, 2026.
Team · 19 people
from the firm's websiteOne of Germany's founding fathers of impact investing. In 2002, initiated the founding of BONVENTURE as the first impact investing fund in the German-speaking region. Investment focus includes nature tech, biodiversity, climate, energy, education, and AI-supported business models.
Angela Lawaldt is Managing Partner at BONVENTURE and brings years of experience in building impact-driven business models. She evaluates investments through both financial and social impact lenses.
Co-founded VITAFY BRANDS as COO and Marketing Director, and previously served as a strategy consultant for four years. Her investment focus encompasses sustainable consumption, digital health, and climate resilience.
Studied industrial engineering and founded two startups in Internet of Things and robotics. Previously an investment manager at a technology VC firm. Investment focus includes deep, industrial, and digital tech as well as digital health.
Law degree holder with master's degree in finance and banking. Previously worked as customer advisor in banking and in the project management office of a large insurance group.
Master's degree in Management & Technology with focus on Finance & Accounting and Mechanical Engineering. Gained experience in technology consulting and with a global NGO serving children without parental care.
BONVENTURE's head of communications connecting investors and portfolio companies. Studied political science in Munich, London, Oslo, and Moscow with extensive professional experience.
Advisory partner at BONVENTURE and management consultant at Bain & Company. Previously headed Bain's Frankfurt office and coordinated European M&A consulting activities. Has advised social enterprises for over 10 years.
Holds a Master's degree in Finance & Information Management from Cambridge and Stanford. Has worked across consultancy, banking, M&A, and deep-tech and YC-backed AI startups before joining BonVenture.
Master's degree in Industrial Engineering with experience in finance and account management, primarily within startup environments.
Master's degree in Finance with background in private equity and financial auditing.
Investments · 1 tracked
founders shown can be your intro pathA healthcare startup delivering modern, digitally-supported primary care in rural German regions through hybrid practice models combining on-site teams and telemedicine services.
Frequently asked questions
- What stage does BONVENTURE invest at?
- BONVENTURE invests at the Seed, Series A, Series B stages.
- What is BONVENTURE's typical check size?
- BONVENTURE typically writes checks of $1.2M – $3M.
- What sectors does BONVENTURE focus on?
- BONVENTURE focuses on Digital Health, Healthtech, Impact & Social Good.
- Where is BONVENTURE located?
- BONVENTURE is headquartered in Berlin, DE.
- Does BONVENTURE lead rounds?
- BONVENTURE typically participates in rounds rather than leading them.
Similar investors
Innovestor is a Finnish investment manager that operates across venture capital, real estate, and energy storage sectors. The firm invests in early-stage technology and life science startups, energy-efficient commercial real estate, and battery storage and solar solutions. Innovestor also provides corporate venturing advisory services.
Lerer Hippeau is an early-stage venture capital firm focused on identifying and backing founders before they achieve prominence. The firm actively invests across multiple sectors including AI/ML, healthtech, fintech, enterprise software, and other emerging technology areas.
GHIC is a global health investment fund established to finance innovative products and technologies in vaccine development, antibody research, and emerging infectious disease solutions. The organization structures investment strategies to ensure developed products remain accessible and affordable globally.
Novo Holdings is a holding and investment company managing the assets of the Novo Nordisk Foundation, one of the world's largest enterprise foundations. The firm invests in life science companies across all development stages and manages a diversified portfolio including equities, bonds, real estate, infrastructure, and private equity.
B Capital is a venture capital firm managing $12+ billion in assets under management with 200+ early to late-stage portfolio companies across 9 global locations. The firm operates dedicated stage-based funds supporting entrepreneurs throughout the company-building lifecycle.